Logo Surge

PreCyte surgical the future perioperative standard

With significantly better predictive performance than competitor products and scales, PreCyte Surgical identifies
patients at risk for postoperative complications.

PREDICT SURGICAL COMPLICATIONS

With significantly better predictive performance than existing products and scales, PreCyte Surgical identifies patients at risk for postoperative complications.

By partnering with Surge, clinicans and researchers can monitor the effectiveness of her prevention and treatment protocols throughout the patient pathway to improve outcomes.

Through our PreCyte technology and a standard blood draw, PreCyte Surgical provides real-time information to allow clinicans to tailor their protocols to the biological needs of the individual.

Discover PreCyte Protocol

Pre operative

Anticipate surgical risk

PreCyte enables prediction of
complications with a simple blood test.

Pre operative

Monitor the impact
of interventions

By repeating the test after preoperative
interventions, such as prehab or neoadjuvant
treatment, the healthcare team can monitor
their effectiveness and continually assess
surgical readiness through the preoperative
period.

Pre operative

Anticipate surgical risk

PreCyte enables prediction of
complications with a simple blood test.

Pre operative

Monitor the impact
of interventions

By repeating the test after preoperative
interventions, such as prehab or neoadjuvant
treatment, the healthcare team can monitor
their effectiveness and continually assess
surgical readiness through the preoperative
period.

POSTOPERATIVE

Adapt postoperative
management

At this stage, PreCyte combines information
about the surgery with the immune impact of
the surgical trauma from postoperative analysis
to guide patient monitoring, discharge, and
anticipation and prevention of complications.

SURGERY

Adapt the surgery
to the risk

The knowledge of individual risk gained
through PreCyte guides the surgical decision
making, allowing for optimization of the
approach, technique, and timing of surgery.

POSTOPERATIVE

Adapt postoperative
management

At this stage, PreCyte combines information
about the surgery with the immune impact of
the surgical trauma from postoperative analysis
to guide patient monitoring, discharge, and
anticipation and prevention of complications.

SURGERY

Adapt the surgery
to the risk

The knowledge of individual risk gained
through PreCyte guides the surgical decision
making, allowing for optimization of the
approach, technique, and timing of surgery.

Discover actionables

EMPOWER IMPROVED CARE AND REDUCE HEALTHCARE COSTS

By enhancing the patient journey
and avoiding complications,
PreCyte offers more than outcomes
prediction

With 63 million elective surgeries performed each year in the US, and a 30% complication rate for major surgeries, the impact on patient morbidity and healthcare systems can be devastating: extended hospital stays, readmissions, patient suffering, disability, and even death.

Knowledge of individual risk to predict and prevent complications improves patient outcomes and allows for a surgical risk-adapted length of hospital stay, shifting care towards the outpatient setting. Preventing complications and shortening hospital stays saves billions of dollars in healthcare spending.

Discover medico-economic impacts

Our products in development

Opportunities for co-development

By partnering with Surge, companies and clinicians can develop and monitor their interventions

Develop your actionable

New perioperative interventions can be costly and time-intensive to implement. Armed with PreCyte’s risk prediction, researchers, clinicians, and entrepreneurs can focus on interventions that have a meaningful impact on patient outcomes.

Monitor the efficacy of your actionable

The dynamic nature of the immune system and its importance in outcomes makes it the ideal biological compartment for tracking the real time effect of an intervention using our PreCyte technology at multiple points throughout the patient pathway.

Opportunities for co-development

Closely involved with clinicians to
develop the product

Press Release
Surge announces closing of a €7.5 million fundraising round to decrypt the immune system and transform precision medicine
Press Release
Surge et Arkhn remportent le Challenge AI For Health de la Région Île-de-France grâce au projet PRISMA, une approche innovante pour anticiper les risques post-opératoires avec l’Hôpital Foch
Non classé
Surge voted Start-up of the year at the French-American Business Awards • FABA 2023